Abstract: A reporting syringe, including a barrel in fluid communication with a needle connected with a first end of the barrel, a piston including a plunger, the piston positioned within a second end of the barrel and the plunger having a fluid-tight interaction with an interior of the barrel, and a microprocessor in electronic communication with a switch and a wireless module, the microprocessor configured to send an administration completion data from the wireless module after triggering the switch.

Abstract: A method, computer program product, and computer system for an intelligent injection device for administering medication. The device may include a barrel in fluid contact with a needle connected with a first end of the barrel, a piston including a plunger, the piston positioned within a second end of the barrel and the plunger having a fluid-tight interaction with an interior of the barrel, a microprocessor in electronic communication with a switch and a wireless module, a sensor configured to detect an amount of injectable medication delivered through the needle, where the microprocessor may be configured to: receive sensor datum regarding the amount of injectable medication delivered through the needle, verify the injectable medication delivered conforms to a stored target dosage, which is a prescribed dosage for a recipient, and transmit administration data regarding the injectable medication delivered through the needle from the wireless module.

Abstract: An intelligent dosing platform system for prior authorization and pharmacy benefit management comprising intelligent injection devices with prior authorization modules configured to receive medication release approval from pharmacies, distributing agents, and payor entities. The system analyzes authorization requirements by evaluating individual payor policies, pharmacy benefit manager formulary restrictions, step therapy requirements, medical necessity criteria, seasonality factors, and timing considerations. An automated decision engine determines authorization approval or denial based on real-time policy evaluation and aggregated device usage data from multiple injection devices. An action coordinator triggers downstream processes including preventing device shipment, updating electronic health records, and coordinating billing system updates.

Abstract: A method, computer program product, and computer system for an injectable administration compliance platform for real-time monitoring and management of adherence to a program for administration of a set of injectables. The platform may include: a server to receive administration data from a wireless module associated with an intelligent injection device. The administration data may include at least one of: an injection device ID, a drug ID, a patient ID, a potency value, an administration completion flag, a timestamp, or temperature data. A database may store treatment schedules. An artificial intelligence module may: calculate a compliance score, and compare the compliance score to a compliance threshold to categorize the injection event. An alerts module may be included. A monitoring system may track user compliance in substantially real-time. A recommendation system may generate health suggestions. The platform may further include a reporting module, a verification module, and a dashboard.

Abstract: A reporting injection device, including a barrel in fluid communication with a needle connected with a first end of the barrel, a piston including a plunger, the piston positioned within a second end of the barrel and the plunger having a fluid-tight interaction with an interior of the barrel, and a microprocessor in electronic communication with a switch and a wireless module, the microprocessor configured to send an administration data from the wireless module after triggering the switch.

Abstract: A device may receive, by an intelligence analytics module of an intelligent dosing platform at least one applicable governance standard from a governance library. A device may determine, by the intelligence analytics module based on the at least one applicable governance standard, at least one analysis type to be performed regarding the request. A device may execute, by an artificial intelligence module of the intelligent dosing platform, the at least one analysis type with respect to the request according to the at least one applicable governance standard. A device may generate, based on a result of the at least one analysis type, a determination regarding whether to permit the requested dosage administration or the requested device control decision, wherein the determination accounts for compliance with the at least one applicable governance standard.

Abstract: An intelligent dosing platform incorporating comprehensive social media integration and patient support network capabilities for injectable medication administration. The platform includes social media interface modules configured to facilitate medication-related communications across multiple social platforms, dosage detection modules that automatically trigger social media notifications and support group communications upon medication administration events, and patient network modules that connect patients with support groups and other patients with similar medication regimens. The system features agentic social network modules utilizing personal data assistants, personal LLM agents for automated content generation and scheduling management, and personal IoT network devices for enhanced social graph updates. Privacy management modules ensure HIPAA compliance while enabling user-controlled sharing of medication milestones and treatment achievements.

Abstract: A method, computer program product, and computer system for a platform for managing injectable medication administration verification. The platform may include: a server configured to receive administration data from an intelligent injection device, a database configured to store treatment schedules, an artificial intelligence module configured to categorize injection events based on compliance with treatment schedules, and a verification module configured to: validate authenticity of intelligent injection devices, verify user identity prior to injection administration, prevent medication errors in institutional settings, and ensure proper medication administration.

Abstract: A method, computer program product, and computer system for a platform for managing injectable medication administration alerts. The platform may include: a server configured to receive administration data from an intelligent injection device, a database configured to store treatment schedules, an artificial intelligence module configured to categorize injection events based on compliance with treatment schedules, and an alerts module configured to: generate and send notifications based on injection event categorization, deliver alerts related to health, biometrics, medications and injections, provide visual and audible outputs regarding injection administration, and warn users about detected behaviors that may negatively impact treatment.

Abstract: An intelligent injection device may determine, by an intelligence analytics module based on a characteristic of the administration data, a reporting authority to whom the administration data should be reported. A device may determine, by the intelligence analytics module for the reporting authority, a reporting format appropriate to the reporting authority. A device may determine, by the intelligence analytics module, a reporting timing parameter for the reporting authority. A device may determine, by the intelligence analytics module, a necessary audit data element to be included in a report to the reporting authority. A device may generate, by a reporting module of the intelligent dosing platform, a report for the reporting authority based on the determined reporting format, the determined reporting timing parameter, and the determined necessary audit data element.

Abstract: A device may analyze, by an artificial intelligence module of the intelligent dosing platform, a pattern in medication administration across a different geographic location to identify a location-based trend in pharmaceutical delivery. A device may identify, by the data fusion engine, a data package for commercial distribution to a third party based on the administration data and the location-based trend, wherein the data package comprises at least one of an aggregated data summary, a simulation result, or a prediction output. A device may package, by the data fusion engine, the identified data package into a commercial product. A device may make available, through the data marketplace interface, the commercial data product to the third party for a commercial transaction, wherein the third party is selected from a pharmaceutical entity, a healthcare provider entity, a healthcare payor entity, a regulatory authority entity, or a research organization entity.

Abstract: An intelligent dosing platform system for emergency medication administration comprising intelligent injection devices with emergency protocol modules, time-based tracking systems, and AI-driven prompting systems. The system analyzes time-based administration protocols for emergency medications, monitors elapsed time since previous medication administrations, and generates next dose prompts based on protocol timing requirements and elapsed time data. A field coordination module transmits administration timing data between field emergency response teams and remote coordination systems. The system supports emergency response environments including cardiac emergencies, anaphylaxis, opioid overdose response, and military field operations. Multi-modal alert systems deliver dose prompts through audible alerts, visual electronic medical record prompts, and remote physician communications.

Abstract: An intelligent dosing platform system for device lifecycle management and predictive maintenance comprising intelligent injection devices with sensors configured to detect operational parameters, device monitoring modules tracking sensor calibration state, battery life metrics, and device performance data. A predictive analytics module analyzes device operational data to forecast maintenance timing, sensor calibration requirements, and device replacement needs. The system includes maintenance scheduling modules that generate automated maintenance alerts based on predicted device performance degradation. A lifecycle documentation module maintains comprehensive device history records including deployment dates, calibration events, maintenance activities, and retirement tracking.

Abstract: A device may maintain, by a governance module of an intelligent dosing platform, a governance library comprising an operation rule and a criterion regarding appropriate use of an intelligent injection device. A device may create, by a digital twin module of the intelligent dosing platform, a digital twin embodiment. A device may generate, by an intelligence analytics module of the intelligent dosing platform based on the governance library operation rule and the criterion and the digital twin embodiment, a personnel training protocol tailored to a specific personnel role. A device may deliver, through a training system of the intelligent dosing platform, an interactive training experience. A device may monitor, by the intelligence analytics module, personnel training performance. A device may calculate, by an artificial intelligence module of the intelligent dosing platform, a training competency score based on conformance of trainee performance to the governance library operation rule and the criterion.

Abstract: A device may receive, by an intelligence analytics module of an intelligent dosing platform at least one applicable governance standard from a governance library. A device may determine, by the intelligence analytics module based on the at least one applicable governance standard, at least one analysis type to be performed regarding the request. A device may execute, by an artificial intelligence module of the intelligent dosing platform, the at least one analysis type with respect to the request according to the at least one applicable governance standard. A device may generate, based on a result of the at least one analysis type, a determination regarding whether to permit the requested dosage administration or the requested device control decision, wherein the determination accounts for compliance with the at least one applicable governance standard.

Abstract: An intelligent dosing platform system for medication authentication and anti-counterfeiting comprising intelligent injection devices with authentication modules, artificial intelligence modules, and fraud detection capabilities. The system utilizes multi-modal verification including visual recognition, RFID/NFC communication, and blockchain validation to authenticate medications and devices. An authentication module analyzes medication identification data to determine authenticity status, while an AI module generates authenticity scores based on visual recognition data, radio-frequency identification data, near-field communication data, and blockchain verification data. The fraud detection module identifies characteristics of counterfeit pharmaceuticals and fraudulent devices. A locking mechanism prevents medication administration when authentication scores fall below predetermined thresholds.

Abstract: An intelligent dosing platform system for prior authorization and pharmacy benefit management comprising intelligent injection devices with prior authorization modules configured to receive medication release approval from pharmacies, distributing agents, and payor entities. The system analyzes authorization requirements by evaluating individual payor policies, pharmacy benefit manager formulary restrictions, step therapy requirements, medical necessity criteria, seasonality factors, and timing considerations. An automated decision engine determines authorization approval or denial based on real-time policy evaluation and aggregated device usage data from multiple injection devices. An action coordinator triggers downstream processes including preventing device shipment, updating electronic health records, and coordinating billing system updates.

Abstract: A content management system for injectable medication administration provides personalized educational content and behavioral incentives based on user demographics and medication needs. The system includes modules for targeting relevant content and incentives based on behavioral patterns, analyzing engagement metrics, and generating performance reports. An authorization module controls content distribution and enables dynamic copay adjustments based on compliance. The system incorporates gamification elements, behavioral economics-based incentives, and points-based rewards to encourage medication adherence. Analytics capabilities track user engagement, monitor behavioral responses, and measure program effectiveness while maintaining compliance-based reward tracking.

Abstract: Methods and systems are disclosed for obtaining and using multi-modal data and its derivatives within an intelligent injection device platform. A device may establish wireless communication connections with a plurality of intelligent injection devices deployed across a healthcare network. A device may continuously collecting real-time geolocation coordinates from each intelligent injection device using an integrated geolocation detection system. A device may receive administration data from the intelligent injection devices. A device may transmit the geolocation data and administration data to a centralized AI-powered software system using a real-time connectivity module. A device may analyze, by an artificial intelligence module, patterns in medication administration across different geographic locations within the healthcare network. A device may correlate geolocation data with treatment schedules and patient outcomes to identify location-specific trends.

Abstract: A device may establish communication between the intelligent injection device and a veterinary artificial intelligence platform configured with species-specific treatment protocols and veterinary medical standard enforcement capabilities. A device may analyze, via the veterinary artificial intelligence platform, animal patient characteristics. A device may apply at least one veterinary medical standard constraint to restrict medication selection, dosage calculations, and administration techniques to only those conforming to an approved veterinary therapeutic guideline for the identified animal species. A device may generate real-time veterinary guidance through the artificial intelligence platform including injection site selection optimized for animal anatomy, needle insertion depth appropriate for species-specific tissue characteristics, and administration timing coordinated with veterinary treatment schedules.